Source: Annual Congress 2012 - COPD epidemiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P.W. Jones, G. Nadeau, M. Small, L. Adamek (London, Uxbridge, Macclesfield, United Kingdom). Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework. Eur Respir J 2012; 40: Suppl. 56, 988

Member's Comments

No comment yet.

Related content which might interest you: Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Cardiovascular comorbidity in severe COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The 2006 and 2011 GOLD classifications and five-years mortality in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Prevalence and severity of GOLD defined COPD in adults Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Poor agreement between chart-based and objectively identified comorbidities of COPD Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 COPD GOLD classification in patients with COPD-OSA overlap syndrome Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013